Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
3
2019
Privacy Tip #210 – HHS Office of Inspector General Issues Fraud Alert for Genetic Testing Scam Targeting Seniors Robinson & Cole LLP
Apr
15
2021
The Endless Frontier Act: Shifting the Focus from Defense to Offense Robinson & Cole LLP
May
25
2022
Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws Robinson & Cole LLP
Nov
7
2019
Stalemate in Use of DNA Profiles from Consumer Databases to Help Crack Cold Cases Robinson & Cole LLP
May
15
2020
Executive Order to Address Zoning Barriers to Re-opening Restaurants and Retail Robinson & Cole LLP
Jan
16
2019
Physician Convicted of HIPAA Violation Receives Probation Robinson & Cole LLP
Nov
10
2022
California Bans the Manufacture and Sale of Certain PFAS-Containing Products Robinson & Cole LLP
Sep
18
2019
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices Robinson & Cole LLP
Jul
12
2023
Connecticut Places Checks on PBM Contracts in Support of 340B Covered Entities Robinson & Cole LLP
Aug
18
2021
Connecticut’s Recreational Marijuana Law And Its Impact on the Workplace Robinson & Cole LLP
Feb
22
2022
Delaware District Court Determines that HRSA Enforcement Letter Targeting 340B Program Restrictions Violates the APA Robinson & Cole LLP
Nov
24
2021
Court Denies GrubHub’s Motion to Dismiss in TCPA Class Action Robinson & Cole LLP
Feb
6
2019
HHS Proposes to Amend AKS Safe Harbors to Exclude PBM Rebates and Incentivize Consumer Drug Discounts Robinson & Cole LLP
May
12
2022
U.S. Agricultural Machinery Manufacturer Hit with Ransomware Attack Robinson & Cole LLP
May
29
2019
Legal Pot = Storm Clouds for Manufacturers Robinson & Cole LLP
Jun
16
2023
Privacy Tip #364 – Montana Enacts Genetic Information Privacy Law Robinson & Cole LLP
Mar
23
2020
COVID-19: HHS Issues FAQs on HIPAA and Telehealth to Help Providers Maintain Access to Care During the Pandemic Robinson & Cole LLP
Sep
21
2023
Joint Advisory Warns of Snatch Ransomware Robinson & Cole LLP
Dec
15
2020
Supreme Court Rules that ERISA Does Not Preempt State Law Regulating PBM Reimbursements Robinson & Cole LLP
Dec
14
2021
CMS Issues Memorandum Stating It Will Not Enforce Its COVID-19 Vaccine Mandate While There are Court-Ordered Injunctions in Place Robinson & Cole LLP
Oct
7
2021
Drones in Agriculture May Keep the Farm Going Robinson & Cole LLP
Apr
8
2019
CBD Update: FDA Issues Statement, Calls Public Hearing, and Announces Warning Letters on Products Containing Cannabis and its Components Robinson & Cole LLP
Jun
4
2019
OIG Issues Alert to Warn of ‘Free’ Genetic Testing Scams Seeking to Steal Information Robinson & Cole LLP
Sep
3
2019
Spurred by Opioid Crisis, Government Proposes Additional Changes to Substance Use Disorder Confidentiality Regulations to Facilitate Provision of Coordinated Care Robinson & Cole LLP
Mar
25
2020
Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure Robinson & Cole LLP
Mar
26
2020
Massachusetts Issues COVID-19 Orders and Related Guidance for Pharmacies and Pharmacy Professionals Robinson & Cole LLP
Sep
1
2021
Considerations for Employers Thinking about COVID-19 Vaccine Mandates Robinson & Cole LLP
Sep
30
2021
Biometric Information Privacy Programs Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins